XORTX Therapeutics (XRTX) Gains from Investment Securities (2021 - 2025)
XORTX Therapeutics' (XRTX) quarterly Gains from Investment Securities came in at $26924.0 in Q4 2025, down 78.78% on a QoQ basis from $126880.5 in Q1 2022.
XORTX Therapeutics (XRTX) Gains from Investment Securities (2021 - 2025) Analysis & Trends
XORTX Therapeutics (XRTX) has 3 years of Gains from Investment Securities data on file, last reported at $26924.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26,924.00 |
| Dec 31, 2025 | 26,924.00 |
| Mar 31, 2022 | 126,880.54 |
| Mar 31, 2022 | 126,880.54 |
| Mar 31, 2021 | 1,280.75 |
| Mar 31, 2021 | 1,280.75 |